NCT02749747View on ClinicalTrials.gov

Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions
Menopausal SyndromeHot Flashes
Interventions
DRUG

Sulpiride use

50mg sulpiride once a day use for 60 days

DRUG

Placebo

50mg placebo once a day use for 60 days

Trial Locations (1)

90035903

Hospital de Clínicas de Porto Alegre, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT02749747 - Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric | Biotech Hunter | Biotech Hunter